An advocacy group is pushing for more ‘human challenge’ trials to spur vaccine discovery. Following COVID-19 and Zika studies, hepatitis C could be next. An advocacy group is pushing for more ‘human challenge’ trials to spur vaccine discovery. Following COVID-19 and Zika studies, hepatitis C could be next.